Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.02M Buy
3,270
+247
+8% +$72.9K 0.08% 117
2024
Q4
$788K Buy
3,023
+287
+10% +$85.2K 0.06% 128
2024
Q3
$882K Buy
2,736
+87
+3% +$28.5K 0.06% 121
2024
Q2
$828K Buy
2,649
+27
+1% +$7.93K 0.07% 122
2024
Q1
$745K Buy
2,622
+116
+5% +$33.9K 0.07% 115
2023
Q4
$722K Buy
2,506
+137
+6% +$37.3K 0.07% 107
2023
Q3
$637K Buy
2,369
+131
+6% +$32.7K 0.07% 102
2023
Q2
$497K Buy
2,238
+27
+1% +$6.26K 0.06% 108
2023
Q1
$535K Buy
2,211
+6
+0.3% +$1.47K 0.06% 106
2022
Q4
$579K Buy
2,205
+940
+74% +$252K 0.07% 102
2022
Q3
$285K Buy
1,265
+260
+26% +$63K 0.05% 109
2022
Q2
$245K Sell
1,005
-302
-23% -$74K 0.04% 105
2022
Q1
$316K Sell
1,307
-350
-21% -$80.4K 0.04% 98
2021
Q4
$373K Buy
1,657
+352
+27% +$74.3K 0.05% 89
2021
Q3
$278K Buy
1,305
+40
+3% +$9.21K 0.05% 75
2021
Q2
$308K Hold
1,265
0.05% 74
2021
Q1
$315K Buy
1,265
+260
+26% +$62K 0.06% 73
2020
Q4
$231K Hold
1,005
0.05% 77
2020
Q3
$255K Hold
1,005
0.06% 74
2020
Q2
$237K Hold
1,005
0.06% 81
2020
Q1
$204K Buy
+1,005
New +$220K 0.06% 77

Other funds holding AMGN

Callan Capital's AMGN Position: Q1 2025 in Review

Callan Capital increased its Amgen (AMGN) stake by 8.2% in Q1 2025, buying an estimated $72.9K and bringing the position to 3,270 shares worth $1.02M. The position accounts for 0.08% of the portfolio, ranked #117.

Callan Capital first reported a position in AMGN in Q1 2020 and has held it in 21 quarters since. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Callan Capital held 3,270 shares of Amgen worth $1.02M as of Q1 2025.
  • Callan Capital bought 247 Amgen shares in Q1 2025, an estimated $72.9K.
  • Amgen made up 0.08% of Callan Capital's portfolio in Q1 2025, its #117 holding.
  • Callan Capital first reported a position in Amgen in Q1 2020 and has held it in 21 quarters since.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.